International Forum of Acute Care Trialists

International Forum of Acute Care Trialists
Name	International Forum of Acute Care Trialists
Abbreviation	IFACT (informal)
Formation	2006
Type	Non-profit research consortium
Headquarters	Geneva
Region served	Global

International Forum of Acute Care Trialists is an international consortium of clinical researchers, trialists, and institutions focused on randomized trials and evidence synthesis in acute care settings. Founded to accelerate multicenter randomized controlled trials in emergency medicine, critical care, and perioperative medicine, the Forum brings together academic centers, hospitals, funders, and guideline bodies to coordinate study design, data standards, and rapid knowledge translation. Its activities interface with regulatory agencies, professional societies, and global health organizations to influence practice and policy across United States, United Kingdom, Canada, Australia, France, Germany, India, China, South Africa, Brazil, and other jurisdictions.

History

The Forum was established in the mid-2000s by clinicians linked to major trial networks and academic centers such as National Institutes of Health, Medical Research Council (United Kingdom), Canadian Institutes of Health Research, University of Oxford, Harvard Medical School, University of Toronto, Imperial College London, and Karolinska Institutet. Early leadership included investigators affiliated with landmark trials and organizations like NIHR, European Society of Intensive Care Medicine, Society of Critical Care Medicine, American College of Emergency Physicians, and the World Health Organization. Initial efforts mirrored the collaborative models used by consortia such as RECOVERY Trial, ISARIC, SPIN Trial, and Cochrane Collaboration, adapting them to acute care trial methodology, pragmatic trial design, and adaptive platform trials. Growth was catalyzed by global health events and emergency research needs, drawing interest from regulatory bodies such as the European Medicines Agency and the Food and Drug Administration.

Mission and Objectives

The Forum’s mission emphasizes coordinated multicenter randomized trials, methodological innovation, and rapid translation into guidelines produced by organizations like National Institute for Health and Care Excellence, Surviving Sepsis Campaign, American Heart Association, European Resuscitation Council, and World Health Organization. Objectives include harmonizing core outcome sets promoted by groups such as COMET Initiative, improving data standards compatible with repositories like ClinicalTrials.gov and ISRCTN Registry, and fostering capacity-building in low- and middle-income settings in collaboration with entities like Bill & Melinda Gates Foundation, Wellcome Trust, and UNICEF. The Forum advocates for ethical oversight aligned with Declaration of Helsinki and trial reporting consistent with CONSORT guidelines.

Organizational Structure

Governance features a steering committee drawn from senior investigators at institutions including Johns Hopkins University, Mayo Clinic, McMaster University, Massachusetts General Hospital, and Charité – Universitätsmedizin Berlin. Operational arms include methodology working groups with members from London School of Hygiene & Tropical Medicine, University of Edinburgh, University of Melbourne, and Uppsala University, data coordination centers modeled on SCORE Trial infrastructure, and a patient and public involvement panel inspired by practices at Patient-Centered Outcomes Research Institute. Funding and oversight interact with philanthropic organizations such as Gates Foundation, government funders like Australian National Health and Medical Research Council, and multilateral funders such as European Commission programs.

Key Research Initiatives and Trials

The Forum has coordinated or supported pragmatic multicenter trials and platform studies in sepsis, acute respiratory failure, cardiac arrest, trauma, and perioperative complications, building on methods from trials like RECOVERY Trial, SOLIDARITY Trial, SAFE Study, and ARREST Trial. It has promoted adaptive platform designs similar to those used by REMEMBER Trial and integrated biomarker and translational components leveraging biobank partnerships with universities such as Stanford University and University of California, San Francisco. Outcomes work aligns with initiatives led by International Sepsis Forum and Global Sepsis Alliance, while statistical and health-economics contributions echo methods from International Stroke Trial and LANDMARK Trial investigators.

Collaborations and Partnerships

The Forum partners with professional societies and networks including European Society of Anaesthesiology, American Thoracic Society, International Liaison Committee on Resuscitation, International Committee of the Red Cross for field research ethics, and regional networks such as Asian Critical Care Clinical Trials Group and African Critical Care Network. It engages with funders and data platforms like Wellcome Trust, Bill & Melinda Gates Foundation, European Commission Horizon 2020, and academic publishers such as The Lancet, New England Journal of Medicine, and BMJ to promote open science and rapid dissemination. Collaboration extends to patient advocacy groups like Sepsis Alliance and regulatory agencies including European Medicines Agency and Food and Drug Administration for trial licensure and guidance.

Impact and Influence on Acute Care Practice

Through coordinated trials, methodological guidance, and guideline engagement, the Forum has influenced recommendations from bodies such as Surviving Sepsis Campaign, American Heart Association, European Resuscitation Council, and national health services including NHS England. Its work has contributed to changes in resuscitation protocols, sepsis bundles, transfusion practices, and perioperative risk management reflected in practice at institutions like Cleveland Clinic and Johns Hopkins Hospital. Publications arising from Forum-affiliated trials appear in major journals including The Lancet, New England Journal of Medicine, and JAMA, shaping clinical pathways and training curricula at medical schools such as Harvard Medical School and University of Oxford.

Category:Medical research organizations